Seroprevalence and demographic determinants of human t-lymphotropic virus type-1 and -2 infections among first-time blood donors, u.s. 2000-2009
Learning Areas:Conduct evaluation related to programs, research, and other areas of practice
Implementation of health education strategies, interventions and programs
Public health or related research
Name the routes of transmission for the Human T-lymphotropic virus (HTLV). Describe global prevalence rates of HTLV. Explain the change in demographic determinants of a rare virus at the national level in the U.S. Compare current prevalence of HTLV 1 and 2 virus to past prevalence from 20 years ago. Identify the demographic determinants and risk factors of population subgroups for being seropositive for HTLV virus. Differentiate the geographic determinants of HTLV and the difference in routes of transmission among populations.
Keyword(s): Epidemiology, Public Health
Qualified on the content I am responsible for because: I analyzed the data and wrote the manuscript for future publication as a epidemiology intern at the Blood Systems Research Institute, and worked on the project for my masters thesis.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.